A randomized controlled phase II clinical trial comparing ONO‐4053, a novel DP1 antagonist, with a leukotriene receptor antagonist pranlukast in patients with seasonal allergic rhinitis
K. Okubo; K. Hashiguchi; T. Takeda; K. Baba; H. Kitagoh; H. Miho; H. Tomomatsu; S. Yamaguchi; M. Odani; H. Yamamotoya
Author Information: Department of Otorhinolaryngology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.